ArticleFrontiers in endocrinology2026
Multi-omics Mendelian randomization integrating metabolism, microbiome and immunity supports a putative gut-immune-pelvic pathway in deep infiltrating endometriosis.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Deep infiltrating endometriosis (DIE) is a highly fibrotic and deeply invasive subtype of endometriosis that causes severe pelvic pain, infertility and marked impairment of quality of life. Metabolic, microbial and immune disturbances have been reported in women with endometriosis, but whether these systemic perturbations causally contribute to DIE and which lesion-level molecular mediators connect them to pelvic pathology remains unknown. Methods: We performed two-sample Mendelian randomization (MR) to assess the causal effects of circulating metabolites, gut microbiota (GM) traits and immune cell phenotypes on DIE risk using genome-wide association data from FinnGen and large exposure GWAS. Bayesian colocalization was applied to identify protein-coding genes with shared causal variants between exposures and DIE. Colocalized genes were integrated with RNA-sequencing data from GSE141549 (normal endometrium, n = 43; DIE lesions, n = 88) to evaluate differential expression and immune-cell associations inferred by CIBERSORT-like deconvolution. Machine-learning-based feature selection was used to derive a multigene logistic model, and protein expression of feature genes was validated by immunohistochemistry in independent specimens. Results: MR revealed putative causal associations between multiple circulating metabolites, GM taxa and immune phenotypes and DIE susceptibility, including risk-increasing bile acid-related and acylcarnitine species, specific bacterial taxa, and monocytic/dendritic-cell traits, and protective lipid species, short-chain-fatty-acid-linked genera and CD45RA Conclusion: This multi-omics MR framework supports a putative gut-immune-pelvic pathway in DIE and identifies a biologically plausible five-gene tissue-level signature consistent with lesion-associated fibrotic and immune-inflammatory remodeling.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.